Abpro Holdings, Inc.(ABPWW)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 35 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ABPWW Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Abpro Holdings, Inc. (ABPWW), a Healthcare sector company. ABPWW is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 35 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q1 2026), Abpro Holdings, Inc. reports net income of $-1.0M, free cash flow of $-2.1M. Top institutional holders of ABPWW by reported 13-F value include VANGUARD GROUP, GOLDMAN SACHS GROUP, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. ABPWW trades on the Nasdaq exchange and files with the SEC under CIK 1893219. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ABPWW daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Abpro Holdings, Inc. directly from SEC EDGAR.
Net Income
Q1 2026
$-1.0M
Free Cash Flow
Q1 2026
$-2.1M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
Net Income
Operating Income
+28.0% YoYEPS (Diluted)
-6303.9% YoYTotal Assets
-97.2% YoYOp. Cash Flow
+18.9% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | — | $122.0K | — | — |
| Net Income | — | $2.8M +218.1% | $886.9K | — |
| Operating Income | $-8.5M +28.0% | $-11.7M -472.9% | $-2.1M | — |
| EPS (Diluted) | $-1.30 -6303.9% | $-0.02 | — | — |
| Total Assets | $1.1M -97.2% | $37.4M -88.0% | $310.6M +85839.3% | $361.4K |
| Operating Cash Flow | $-6.0M +18.9% | $-7.4M -524.7% | $-1.2M | — |
AI Insight: ABPWW Financial Trends
Abpro is narrowing operating losses and equity deficit, but revenue remains absent and cash burn persists.
• Operating income loss shrunk from $-8M in Q4 2024 to $-1M in Q1 2026, showing sequential improvement.
• Equity deficit contracted from $-18M in Q1 2025 to $-3M in Q1 2026, indicating reduced balance-sheet stress.
• Operating cash flow remains negative across all 8 quarters, ranging $-8M to $1M, with no sustained positive generation.
⚠ Revenue is completely absent from reported financials; operational viability and business model clarity unverifiable.
⚠ Operating cash burn resumed in Q1 2026 ($-2M) after improvement in Q2–Q3 2025, signaling potential cash-runway concern.
AI Insight: ABPWW Ratio Trends
Insufficient data to assess trends — only two ROA readings available, both negative, with all other metrics missing across the period.
• ROA deteriorated marginally from -17.2% in Q2 2024 to -17.1% in Q3 2024, indicating persistent asset-unprofitability.
⚠ Complete absence of OpMargin, NPM, ROE, ROIC, and D/E data from Q4 2024 onward prevents trend analysis or leverage assessment.
Get alerted when ABPWW's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Abpro Holdings, Inc. including:
Top Institutional Holders of ABPWW
VANGUARD GROUP INC
$85.0K20,084 shGOLDMAN SACHS GROUP INC
$52.4K12,383 shGEODE CAPITAL MANAGEMENT, LLC
$45.6K10,785 shSaba Capital Management, L.P.
$16.4K997,048 shJPMORGAN CHASE & CO
$12.2K873,533 shMMCAP International Inc. SPC
$11.1K675,000 shCalamos Advisors LLC
$10.6K625,000 shAQR Arbitrage LLC
$9.0K546,540 shLMR Partners LLP
$8.8K2,084 shLINDEN ADVISORS LP
$8.5K499,999 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD GROUP INC | $85.0K | 20,084 |
| GOLDMAN SACHS GROUP INC | $52.4K | 12,383 |
| GEODE CAPITAL MANAGEMENT, LLC | $45.6K | 10,785 |
| Saba Capital Management, L.P. | $16.4K | 997,048 |
| JPMORGAN CHASE & CO | $12.2K | 873,533 |
| MMCAP International Inc. SPC | $11.1K | 675,000 |
| Calamos Advisors LLC | $10.6K | 625,000 |
| AQR Arbitrage LLC | $9.0K | 546,540 |
| LMR Partners LLP | $8.8K | 2,084 |
| LINDEN ADVISORS LP | $8.5K | 499,999 |
More Healthcare Companies
View all Healthcare →Put ABPWW on your watchlist
Track score changes the day Abpro Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ABPWW a good stock to buy?
13F Pro's AI-powered analysis of Abpro Holdings, Inc. (ABPWW) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ABPWW are available on the ABPWW stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ABPWW?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ABPWW. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Abpro Holdings, Inc.'s investment landscape.